Niche has collaborated with the BSH for the development of guidelines, important for raising standards of care in haematology. This has involved conducting literature searches, providing writing support and generating documentation for auditing compliance to guidelines since 2013.
Niche has supported the development of over 20 guidelines that have covered the diagnosis and management of diverse haematological indications, including cancer-related venous thrombosis, mantle cell lymphoma, aplastic anaemia and antiphospholipid syndrome.
"I am pleased by the standard of work delivered by Niche. The writers provide confidence in the written documents they produce and they excel at clear communication. In addition, the contracting process is simple and efficient, communication is open, frequent and proactive, with any issues getting resolved quickly and efficiently."
Bridging the research-practice gap and raising standards of clinical and patient care, through guidelines, are central to the BSH’s mission. Niche has assisted in this, by supporting the development of robust guidelines that reflect the latest research, experience and clinical expertise. This has involved capturing up-to-date data in literature searches for subsequent abstraction, synthesis and evaluation. When required, Niche has worked closely with authors for writing support and guideline finalisation. Moreover, Niche has assisted the BSH in drafting documentation for auditing guideline compliance.
The collaboration between the BSH and Niche has lasted over a decade. Key to this is straightforward contracting, seamless meshing of both teams, proactive communication and dissemination of insights. Niche’s collective pool of knowledge, alongside familiarity with the BSH’s ethos and processes, has enabled the delivery of high-quality deliverables.
The BSH’s guidelines have incorporated expertise from several sub-specialties, covering the diagnosis and management of various haematological indications. These include cancer-related venous thrombosis, mantle cell lymphoma, aplastic anaemia, sickle cell disease in pregnancy and antiphospholipid syndrome.
When stalled regulatory documentation threatened to derail their neurological programme, Cleothena turned to Niche —.
read morePutting patients first, Niche supported ViiV Healthcare's global HIV outreach programmes with medical writing,.
read moreNiche provided Astex with expert regulatory writing across their oncology pipeline, delivering clinical protocols, study.
read moreNiche supported Nabriva's antibiotic lefamulin from early clinical protocols all the way to FDA, EMA and Health Canada.
read moreNiche built and coordinated the full communications strategy for this 20-institution European initiative, turning.
read moreNiche delivered rigorous QC and medical writing support across Adaptimmune's full suite of regulatory documents, keeping.
read moreFrom Phase 2 through to the global Phase 3 HEAL-MI trial, Niche has been Recardio's trusted writing and regulatory.
read moreAt the height of the pandemic, Niche's rapid manuscript writing helped Synairgen publish their landmark interferon beta.
read moreFor over a decade, Assign DMB relied on Niche as their embedded writing partner, seamlessly converting statistical.
read moreA trusted writing partner to this Belfast-based early-phase CRO for over a decade, Niche turned BioKinetic Europe's.
read moreNiche served as the English-language regulatory writing backbone for this Nordic consultancy, producing IBs, IMPDs and.
read moreGet our latest news and publications
Sign up to our news letterResources
Social
Contact us
Address
Niche Science & Technology
Unit 26 Falstaff House
Bardolph Road
Richmond TW9 2LH
United Kingdom
